banner
banner
banner
banner
banner
  • Add Favorites
  • Download

3Q22

3Q22

  • 3Q22 Earnings Release

    • Elected the most amazing pharmaceutical company to work for by FIA/USP and UOL
    • Net Revenue recorded 19.5% growth in 3Q22, raising the accumulated growth in 9M22 to 13.2%, reaching R$ 718.3 million
    • Gross margin reaches 52.3% in 3Q22 with 50.6% accumulated margin in 9M22, amounting to R$ 363.2 million in gross profit
    • EBITDA reaches R$ 137.5 million with 9.3% growth
    • Leverage at 1.3x EBITDA, with 75% of debt via FINEP and BNDES

     

     

     

logo Ouro Fino

› Department of Investor Relations

Rodovia Anhanguera, SP 330, KM 298, Bloco C, 2º andarCEP 14140-000 - Cravinhos - São Paulo

Phone: (55 16) 3518-2000

Privacy Policy

Terms and Conditions of Use

Cookies preferences

› Follow Ouro Fino on Social Networks:

All rights reserved
Copyright © 2016 OUROFINO

imgCapctha